Evidence map›Paper›PMID 31807862›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2020

Functional coupling of M

Yuji Odagaki, Masakazu Kinoshita, J Javier Meana, Luis F Callado, Jesús A García-Sevilla

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Characterization of dopamine DPharmacological reports : PR · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Yuji OdagakiDepartment of Psychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan. odagaki@saitama-med.ac.jp.ORCID http://orcid.org/0000-0002-1792-028X
Masakazu KinoshitaDepartment of Psychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
J Javier MeanaDepartment of Pharmacology, University of the Basque Country, UPV/EHU, 48940, Leioa, Bizkaia, Spain.
Luis F CalladoDepartment of Pharmacology, University of the Basque Country, UPV/EHU, 48940, Leioa, Bizkaia, Spain.
Jesús A García-SevillaLaboratory of Neuropharmacology, IUNICS/IdISPa, University of the Balearic Islands (UIB), Palma de Mallorca, Spain.
University of the Basque Country · ESResearch Institute of Health Sciences · ESSaitama Medical University · JPSaitama Medical University Hospital · JP

Funding

Basque Government IT-616-13Saitama Medical University (JP) Internal Grant 18-B-1-03Spanish MINECO-FEDER 2011-29918Spanish MINECO-FEDER SAF 2013-48586-RSpanish MINECO-FEDER SAF 2017-88126R
6 · The paper itself

Abstract

Accumulating studies have implicated intracellular signaling through muscarinic acetylcholine receptors (mAChRs) in psychiatric illness. In the present study, carbamylcholine chloride (carbachol)-induced Gα

Indexed as

Signal TransductionAdultAgedAutopsyBipolar DisorderCarbacholCohort StudiesFemaleGTP-Binding Protein alpha SubunitsGTP-Binding Protein alpha Subunits, Gi-GoHumansMajor Depressive DisorderMaleMiddle AgedPrefrontal CortexReceptor, Muscarinic M1CarbacholCHRM1 protein, humanGNA11 protein, humanGNAI1 protein, humanGTP-Binding Protein alpha SubunitsGTP-Binding Protein alpha Subunits, Gi-GoReceptor, Muscarinic M1Bipolar disorderDorsolateral prefrontal cortexG-proteinMajor depressive disorderMuscarinic acetylcholine receptor (mAChR)Schizophrenia

Identifiers

PMID31807862
OpenAlexW2994266609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.